Symptoms of chronic rhinosinusitis (CRS) include a diminished sense of smell, face pain or pressure, obstruction of the nasal passages, discharge from the nose, and inflammation of the paranasal sinuses and nasal cavity. This condition can remain for at least 12 weeks. The impact on quality of life is severe, and the healthcare burden is enormous on a global scale. Impaired mucociliary clearance, persistent inflammation, microbial colonization, and structural abnormalities are all components of CRS's complex pathophysiology that work together to cause symptoms to persist and recur [1-3].
The use of nasal saline irrigation as an adjuvant treatment for CRS has recently gained popularity due to its simplicity, effectiveness, and low cost. Mucociliary function is improved and local inflammation is reduced by mechanically emptying the nasal cavity of allergens, mucus, and inflammatory mediators. Standard practice in medicine calls for its regular use, either as a stand-alone therapy for moderate instances or in conjunction with other pharmaceuticals such antibiotics and intranasal corticosteroids. Adherence by patients is crucial to the success of nasal saline irrigation, despite its established advantages; adherence can vary greatly owing to variables such discomfort, annoyance, ignorance, and incorrect technique [4, 5].

A key factor in the success of treatment for chronic diseases like CRS is the patient's adherence to prescribed long-term medications. Inadequate symptom management, a heavier disease load, an increased risk of problems, and the eventual necessity for surgical intervention can result from noncompliance. There is a lack of information on actual adherence patterns and how they affect the sustained alleviation of symptoms, even though multiple studies have shown that saline irrigation is clinically effective [6, 7].

Hence, this study was planned as a 6-month prospective survey to examine whether individuals with chronic rhinosinusitis regularly irrigate their noses with saline and whether this practice correlates with alleviation of symptoms according to established outcome metrics. Improving long-term management outcomes in CRS and enhancing patient compliance can be achieved by better understanding adherence behavior and its clinical implications.

Department of ENT, GSL Medical College and Hospital, Rajamahendravaram, Andhra Pradesh, 533296, India ran 6-month prospective observational research between January 2010 to November 2010. Fifty individuals were included in the research after a clinical diagnosis of chronic rhinosinusitis (CRS) was made, with the use of radiological evidence as needed. Prior to inclusion, all individuals were asked to provide written informed consent, and institutional ethics approval was obtained. The Sino-Nasal Outcome Test-22 was used to assess the severity of symptoms in all patients at baseline. We taught our patients how to properly irrigate their noses with isotonic saline solution and told them to do so once a day. Inclusion Criteria: • Patients aged 18–65 years • Patients diagnosed with chronic rhinosinusitis • Patients willing to perform nasal saline irrigation regularly • Patients providing informed consent Exclusion Criteria: • Patients with acute rhinosinusitis • Patients who had undergone recent nasal • Patients with nasal polyposis requiring immediate surgical intervention • Patients with severe systemic illness or immunocompromised status • Patients unable to perform nasal irrigation due to anatomical • Non-compliant patients unwilling to participate in follow-up Statistical Analysis: Statistics programs were used to examine the data. Mean ± standard deviation (SD) was used to express continuous variables like SNOT-22 scores, whilst percentages were used to indicate categorical variables like adherence levels. Using repeated measures ANOVA, we examined the temporal changes in symptom scores. Using a chi-square test and one-way ANOVA, we looked at how adherence levels correlated with the alleviation of symptoms. Statistical significance was determined by a p-value less than 0.05.

A total of 50 patients with chronic rhinosinusitis (CRS) were recruited and completed the 6-month follow-up period. The outcomes were evaluated for demographic characteristics, compliance with nasal saline irrigation, and symptom amelioration as measured by SNOT-22 scores.

Table 1: Demographic and Clinical Characteristics of Patients

Table 1 provides a concise overview of the research population's demographic and clinical profile at baseline. The average age was 41.6 years old, and there was a small male bias. The most common presenting symptom was nasal discharge (76%), followed by nasal blockage (84%). On average, CRS symptoms persisted for about 14 months, suggesting that the study population was dealing with a chronic illness burden.

Table 2: Adherence to Nasal Saline Irrigation Over 6 Months

The levels of adherence among patients are displayed in Table 2. Sixty percent showed very good adherence to nasal saline irrigation, twenty-four percent showed moderate adherence, and sixteen percent showed poor adherence. Despite the fact that the majority of patients adhered to their treatment plans, a sizeable minority demonstrated less-than-ideal compliance.

Table 3: Change in Mean SNOT-22 Scores Over Time

Table 3 shows that SNOT-22 scores have been decreasing at a statistically significant rate. After 6 months of daily nasal saline irrigation, the average score dropped significantly from 48.6 at baseline to 22.8 (p < 0.001), indicating a significant reduction in overall symptoms.

Table 4: Symptom Improvement by Domain at 6 Months

The improvement was seen in Table 4, which covers important categories of symptoms. All symptoms, especially nasal blockage and discharge, were significantly reduced. This demonstrates that nasal saline irrigation is a viable long-term treatment option for CRS symptoms.

Table 5: Association Between Adherence Level and Symptom Improvement

The correlation between adherence and improvement of symptoms is statistically significant (Table 5). Low adherence was linked with little improvement, while patients with good adherence saw the biggest drop in SNOT-22 scores (28.5 points) and the best improvement rate (78%). For the best possible therapeutic results, it is essential to consistently employ nasal saline irrigation.

This prospective study followed individuals with chronic rhinosinusitis (CRS) for 6 months to see whether their symptoms improved based on how often they irrigated their noses with saline. Significant clinical alleviation is related with regular nasal saline irrigation, according to the results, which show improvement across key symptom domains and large reductions in SNOT-22 scores [8-10].
At baseline, a significant number of CRS symptoms, including nasal discharge (76%) and obstruction (84%), were noted, which highlights the chronic inflammatory character of the condition. These results are in line with earlier research that found that the most prevalent and distressing symptoms impacting the quality of life for CRS patients were nasal congestion and discharge. The patients' moderate to severe symptom burden is further shown by the mean baseline SNOT-22 score of 48.6 ± 8.4 [11-13].
The analysis of patterns of adherence is one of the study's strongest points. Nasal saline irrigation was well-adherent to by 60% of patients, with 40% displaying moderate to poor adherence. Despite the fact that nasal irrigation is an easy and inexpensive technique, this shows that patients still have trouble following instructions. Reduced adherence may be caused by factors including discomfort during the procedure, time constraints, a lack of motivation, or difficulty [14-16].

According to the study, symptoms significantly improved as time went on, with mean SNOT-22 scores dropping from 48.6 at the beginning to 22.8 at the end of 6 months (p < 0.001). The improvement in patient-reported outcomes is seen in this reduction, which is clinically meaningful. This improvement is caused by the elimination of allergens and pathogens from the nasal cavity, as well as by improved mucociliary clearance and reduced inflammatory mediators [17,18].

An important finding was a robust association between the extent to which symptoms improved and the adherence to nasal saline irrigation. The most significant decrease in SNOT-22 scores was observed in the high-adherence group (28.5% reduction), followed by the moderate-adherence group (18.2% reduction), and the low-adherence group (10.4 points reduction). Regular and consistent therapy is crucial for getting optimal clinical outcomes, as this finding highlights. This finding is in line with earlier research that has shown that patient compliance is a key factor in determining the effectiveness of treatment for CRS [19].

Results for nasal blockage, discharge, facial pain, and olfactory dysfunction were also significantly improved when analyzed separately. Among these, nasal obstruction improved the most, perhaps because mucus was effectively cleared and mucosal edema was reduced. Although the improvement in olfactory function is not as noticeable, it does show that long-term irrigation has a good effect on sinonasal physiology [20].

The study also highlights the significance of following up with patients and educating them on how to improve their adherence. The relatively high rates of adherence were probably due, in part, to the regular monitoring that occurred during monthly follow-ups, which reinforced the correct method. Clinical practice should incorporate systematic patient counseling and engagement strategies, according to this [21].

It is important to note, nevertheless, that there are some restrictions. Researchers ran the risk of reporting bias since the study depended on participants' own accounts of their adherence. Furthermore, the results may not be applicable to a broader population due to the study's single-center design and the small sample size (n = 50). It is also difficult to compare patients who used nasal irrigation to those who did not because a control group was not included.

Symptoms of chronic rhinosinusitis significantly improved over a 6-month period, and the current study found that nasal saline irrigation was an efficient and safe supplementary treatment. The significant improvement across important symptom dimensions and the dramatic decrease in SNOT-22 scores demonstrate its therapeutic effects. One important factor that was found to be a crucial predictor of treatment success was the patient's compliance with nasal saline irrigation. It is important to utilize the medication consistently and regularly for the best results, as patients with low adherence showed no improvement in symptoms compared to those with high adherence. In order to improve adherence and get the most out of therapy, the results stress the significance of patient education, training in the right techniques, and frequent follow-up. This study lends credence to the use of nasal saline irrigation as part of standard CRS treatment, despite caveats such a small sample size and the use of self-reported data. Funding None Conflict of Interest: None

1. Harvey R, Hannan SA, Badia L, Scadding G. Nasal saline irrigations for the symptoms of chronic rhinosinusitis. Cochrane Database Syst Rev. 2007;(3):CD006394.
2. Pynnonen MA, Mukerji SS, Kim HM, Adams ME, Terrell JE. Nasal saline for chronic sinonasal symptoms. Arch Otolaryngol Head Neck Surg. 2007;133(11):1115–1120.
3. Hopkins C, Gillett S, Slack R, Lund VJ, Browne JP. Psychometric validity of the 22-item Sinonasal Outcome Test. Clin Otolaryngol. 2009;34(5):447–454.
4. Benninger MS, Senior BA. The development of the Rhinosinusitis Disability Index. Arch Otolaryngol Head Neck Surg. 1997;123(11):1175–1179.
5. Lund VJ, Kennedy DW. Quantification for staging sinusitis. Ann Otol Rhinol Laryngol Suppl. 1995;167:17–21.
6. Rosenfeld RM, Andes D, Bhattacharyya N, et al. Clinical practice guideline: adult sinusitis. Otolaryngol Head Neck Surg. 2007;137(3 Suppl):S1–S31.
7. Rabago D, Pasic T, Zgierska A, et al. The efficacy of hypertonic saline nasal irrigation. Arch Fam Med. 2002;11(3):199–205.
8. Rabago D, Zgierska A. Saline nasal irrigation for upper respiratory conditions. Am Fam Physician. 2009;80(10):1117–1119.
9. Wang YH, Yang CP, Ku MS, Sun HL, Lue KH. Efficacy of nasal irrigation in the treatment of chronic rhinosinusitis. Acta Paediatr Taiwan. 2009;50(6):326–331.
10. Heatley DG, McConnell KE, Kille TL, Leverson GE. Nasal irrigation for the alleviation of sinonasal symptoms. Otolaryngol Head Neck Surg. 2001;125(1):44–48.
11. Tomooka LT, Murphy C, Davidson TM. Clinical study and literature review of nasal irrigation. Laryngoscope. 2000;110(7):1189–1193.
12. Keojampa BK, Nguyen MH, Ryan MW. Effects of nasal saline irrigation on nasal symptoms. Ear Nose Throat J. 2004;83(2):110–112.
13. Garavello W, Romagnoli M, Sordo L, Gaini RM, Di Berardino F, Angrisano A. Hypersaline nasal irrigation in children. Int J Pediatr Otorhinolaryngol. 2003;67(6):599–603.
14. Ural A, Oktemer T, Kizil Y, et al. Impact of nasal irrigation on mucociliary clearance. Am J Rhinol Allergy. 2009;23(6):610–612.
15. Freeman SR, Sivayoham ES, Jepson K, Jones NS. Is nasal douching beneficial? Clin Otolaryngol. 2008;33(2):146–151.
16. Hauptman G, Ryan MW. The effect of saline solutions on nasal patency. Otolaryngol Head Neck Surg. 2007;137(5):815–821.
17. Talbot AR, Herr TM, Parsons DS. Mucociliary clearance and buffered saline solution. Laryngoscope. 1997;107(4):500–503.
18. Brown CL, Graham SM. Nasal irrigations: good or bad? Curr Opin Otolaryngol Head Neck Surg. 2004;12(1):9–13.
19. Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: developing guidance for clinical trials. J Allergy Clin Immunol. 2006;118(5 Suppl):S17–S61.
20. Anand VK. Epidemiology and economic impact of rhinosinusitis. Ann Otol Rhinol Laryngol Suppl. 2004;193:3–5.
21. Scadding GK. Rhinitis and rhinosinusitis: pathophysiology and management. Clin Exp Allergy. 2007;37(7):1091–1101.